Luna Place, The Technology Park
DD2 1XA Dundee, Scotland
United Kingdom
Phone: +44 138 2422000
Fax: +44 138 2561201
shield@uk.axis-shield.com
Manufacturers
OEM
Trader
Company Contacts
Department/ Name Address
George Zajicek Tel: 0044-1382-422000
george_zajicek@uk.axis-shield.com
Company Figures
Number of employees 100-499
Sales volume 100-199 Mio US $
Export content > 75%
Year of foundation 1999
Area of business Diagnostics
Company Profile
Axis-Shield produces innovative and important IVD’s
Axis-Shield is a global in vitro diagnostics business with development and manufacturing capabilities and three separate business areas. The company has a Laboratory Division selling to clinical laboratories and OEM partners, a Point-of-Care Division which supplies the near patient test sector, and the distribution businesses of Medinor for the Nordic area, Axis-Shield UK for the United Kingdom and Axis-Shield AG in Switzerland. We sell directly, through our own and third party distributors, and also via OEM contracts.
Our vision is “to improve healthcare as a global provider of innovative in-vitro diagnostic products”, which is backed up by the following Mission Statement:
“To identify and develop novel, patentable in vitro diagnostic products to meet clinical needs in the laboratory and at the point of care. We will collaborate with partners, create branded products, and add complementary businesses which support our objective of growing an innovative and increasingly profitable company”
We believe our products are making a difference and that we are improving lives by offering innovative, high quality, reliable in vitro diagnostic products which promote improved patient management. Customers may use our products with confidence as we operate to the highest quality standards, with well trained technical support staff.
Axis-Shield has proprietary technology in near patient testing with the innovative Afinion system and the long-established NycoCard range, together with a number of patented markers in areas of clinical need. Areas of special focus include cardiovascular and neurodegenerative diseases, rheumatoid arthritis and diabetes. In our home markets of the UK and the Nordic countries we sell not only our own products but also complementary in vitro and other medical devices.
We firmly believe that our products provide clinicians and other healthcare professionals with tools to deliver better patient care. Early, rapid and differential diagnosis of disease in the presence of the patient facilitates the best treatment options and is being increasingly recognised as an essential component of more effective primary care.